NASDAQ: IPHA
Innate Pharma Sa Stock Ownership - Who owns Innate Pharma Sa?

Insider buying vs selling

Have Innate Pharma Sa insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IPHA insiders and whales buy or sell their stock.

IPHA Shareholders

What type of owners hold Innate Pharma Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Exchange Traded Concepts LLC0.07%62,752$109.38kInstitution
Morgan Stanley0.05%43,524$75.86kInstitution
Citadel Advisors LLC0.03%24,267$42.30kInstitution
Millennium Management LLC0.02%15,326$26.71kInstitution
Ubs Group Ag0.01%9,001$15.69kInstitution
Gamma Investing LLC0.00%2,233$3.89kInstitution
Rhumbline Advisers0.00%675$1.18kInstitution
Barclays PLC0.00%307$535.10Institution
Optiver Holding Bv0.00%101$176.04Institution
Tower Research Capital LLC Trc0.00%3$5.23Institution

1 of 2

IPHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IPHA0.19%0.00%
GLSI8.19%91.81%Net BuyingNet Buying
THTX27.77%0.00%
LYEL52.53%47.47%Net Buying
LXEO79.72%20.28%Net BuyingNet Selling

Innate Pharma Sa Stock Ownership FAQ

Who owns Innate Pharma Sa?

Innate Pharma Sa (NASDAQ: IPHA) is owned by 0.19% institutional shareholders, 0.00% Innate Pharma Sa insiders, and 99.81% retail investors. Exchange Traded Concepts LLC is the largest individual Innate Pharma Sa shareholder, owning 62,752.00 shares representing 0.07% of the company. Exchange Traded Concepts LLC's Innate Pharma Sa shares are currently valued at $109.38k.

If you're new to stock investing, here's how to buy Innate Pharma Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.